在使用大麻的创伤患者中,静脉血栓栓塞和凝血生物标志物的变化
Maya J Sorini1, Joseph Fracasso2, Larissa Russo2
1Department of Surgery, Hackensack Meridian School of Medicine, Nutley, NJ, USA.
The American surgeon
|October 29, 2025
概括
这项研究发现,在血栓塞栓症 (VTE) 率或凝血标志物中,创伤患者对大麻素检测阳性和那些检测阴性的人之间没有显著差异. 大麻素的使用没有影响创伤护理中的这些结果.
科学领域:
- 创伤护理 创伤护理
- 药理学 药理学是指药理学的学科.
- 血液学 血液学 血液学
背景情况:
- 在创伤患者中对大麻素使用和血栓栓塞事件的先前研究产生了相互矛盾的结果.
- 了解大麻素与静脉血栓栓塞 (VTE) 之间的关联对于创伤患者的管理至关重要.
研究的目的:
- 调查大麻素使用与创伤患者静脉瘤发病率之间的关联.
- 分析二次结果,包括死亡率,停留时间和凝血生物标志物.
主要方法:
- 追溯性对14岁及以上创伤患者的队列研究.
- 包括尿液药物查 (UDS) 和血液酒精度 (BAC) 结果的患者.
- 用于分析的是一对一的倾向性得分匹配.
主要成果:
- 大麻素阳性 (7.4%) 和大麻素阴性 (4.4%) 组之间的VTE率没有显著差异 (P = .683).
- 血小板计数和凝血概况在两组之间没有显著差异.
- 死亡率,住院时间或出院处置没有显著变化.
结论:
- 这项研究没有发现基于大麻素使用的创伤患者凝血生物标志物或VTE发病率的显著差异.
- 在这一创伤队列中,使用大麻素与静脉瘤风险增加或凝血参数变化无关.
相关概念视频
Venous Thrombosis III: Interprofessional Care
276
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
276
Venous Thrombosis IV: Nursing Management
192
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
192
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
284
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
284
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
665
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
665
Venous Thrombosis I: Introduction
351
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
351
Extrinsic and Intrinsic Pathways of Hemostasis
12.0K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
12.0K


